← Back to Clinical Trials
Recruiting NCT06705907

NCT06705907 Improving Academic and Social Functioning in Middle-Schoolers With Autism

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06705907
Status Recruiting
Phase
Sponsor Children's Hospital Medical Center, Cincinnati
Condition Autism
Study Type INTERVENTIONAL
Enrollment 224 participants
Start Date 2024-12-01
Primary Completion 2029-05-31

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Achieving Independence and Mastery in School (AIMS)Building Essential Social Skills for Teens (BESST)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 224 participants in total. It began in 2024-12-01 with a primary completion date of 2029-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to test how well two group interventions work for middle-school children with Autism Spectrum Disorder (ASD). One of the interventions focuses on teaching parents and adolescent skills to help improve their social functioning and the other focuses on teaching parents and adolescents skills to improve organization, planning, and study skills. Eligible participants will be randomly (like a coin flip) assigned to attend one of the two interventions.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of autism * No intellectual disability * Problems with organization, materials management, and planning and prioritization * Problems with social skills * Fully included in middle school * Stable medication and behavioral treatment regime Exclusion Criteria: * Home schooled * Severe co-occurring psychopathology (e.g., aggression, suicidal) * Non English-speaking

Contact & Investigator

Central Contact

Leanne Tamm, Ph.D.

✉ leanne.tamm@cchmc.org

📞 513-803-3176

Principal Investigator

Leanne Tamm, Ph.D.

PRINCIPAL INVESTIGATOR

Children's Hospital Medical Center, Cincinnati

Frequently Asked Questions

Who can join the NCT06705907 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 15 Years, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06705907 currently recruiting?

Yes, NCT06705907 is actively recruiting participants. Contact the research team at leanne.tamm@cchmc.org for enrollment information.

Where is the NCT06705907 trial being conducted?

This trial is being conducted at Cincinnati, United States.

Who is sponsoring the NCT06705907 clinical trial?

NCT06705907 is sponsored by Children's Hospital Medical Center, Cincinnati. The principal investigator is Leanne Tamm, Ph.D. at Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 224 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology